APOC1 rs6857: Understanding This Genetic Variant
The rs6857 variant is a single nucleotide polymorphism located within the APOE/APOC1 gene cluster on chromosome 19. It is frequently studied alongside neighboring genes for its potential associations with lipid metabolism and neurocognitive healthspan.
What each genotype means
Typical longevity and neurocognitive profile
You carry two copies of the common G allele at rs6857. In genetic research, this genotype represents the standard baseline profile for healthspan and neurocognitive traits in the APOE/APOC1 genomic cluster. Because this region features high linkage disequilibrium with APOE isoforms, individual outcomes are heavily influenced by the broader APOE haplotype.
Carried by approximately 65% to 75% of individuals in European populations, and at even higher rates in East Asian ancestries.
Intermediate longevity association
You carry one copy of the A allele and one copy of the G allele at rs6857. The A allele has been evaluated in aging and longevity studies, frequently tagging neighboring APOE risk haplotypes such as APOE-e4. Current evidence regarding whether rs6857 exerts an independent effect outside of APOE remains limited and mixed across ancestral cohorts.
Found in roughly 25% to 30% of European populations, but less common in East Asian groups.
Altered neurocognitive and lifespan markers
You carry two copies of the minor A allele at rs6857. In population-level association analyses, this genotype is often co-inherited with lipid-altering and neurodegenerative risk haplotypes in the 19q13.32 region. However, direct causative biological effects specifically attributable to rs6857 rather than nearby APOE coding variants remain unconfirmed.
Found in approximately 2% to 4% of European individuals and is rare in most Asian populations.
What is rs6857?
The rs6857 variant is a specific change in the DNA sequence located on chromosome 19. In the context of human genomics, it sits within a highly complex and well-studied region known as the APOE/APOC1 gene cluster. This region is critical because it contains several genes that are essential for how the body processes fats and cholesterol. Because rs6857 is physically close to the APOE gene—a major player in Alzheimer's disease research—scientists often analyze this variant to see if it acts as a marker for broader genetic patterns in the area. It is important to note that being a 'marker' means the variant itself may not be the direct cause of a biological change, but rather that it is inherited alongside other functional changes in the nearby genes.
The Role of the APOC1 Gene
The APOC1 gene encodes Apolipoprotein C1, a protein primarily produced in the liver. This protein is a key component of high-density lipoprotein (HDL) and very low-density lipoprotein (VLDL) particles, which are responsible for transporting fats and cholesterol through the bloodstream. Beyond its role in lipid metabolism, APOC1 is involved in the immune response, specifically when monocytes differentiate into macrophages. Because lipid metabolism is deeply intertwined with cardiovascular and neurological health, researchers investigate APOC1 to understand how variations in its expression might influence long-term health outcomes. While the gene's function in lipid transport is well-established, its specific contribution to complex traits like longevity or cognitive decline remains a subject of ongoing scientific inquiry.
Research Associations and Evidence
Research into rs6857 has primarily focused on its statistical association with neurocognitive health and age-related conditions. Some genome-wide association studies (GWAS) have identified links between this region and markers of cerebral amyloid deposition, which are relevant to Alzheimer's disease research. However, the evidence strength for rs6857 specifically is considered limited. Many of the observed associations are likely due to 'linkage disequilibrium,' a phenomenon where rs6857 is inherited together with other, more influential variants in the neighboring APOE gene. Consequently, it is difficult to isolate the independent effect of rs6857 from the well-documented effects of the APOE ε4 allele. Current research does not support using this variant as a standalone diagnostic tool, as the biological mechanisms are complex and influenced by many other genetic and environmental factors.
Interpreting Your Genetic Information
If you have received information about your rs6857 genotype, it is important to view it within the context of current scientific limitations. Genetic variants like rs6857 are pieces of a much larger puzzle; they do not determine your health destiny. Because the evidence linking this specific SNP to clinical outcomes is limited and often confounded by nearby genes, it is not currently used in clinical practice to predict disease risk or guide medical treatment. You cannot 'fix' or 'change' this variant, and there is no specific lifestyle intervention tailored to this SNP. If you are concerned about your cognitive health or lipid levels, focus on evidence-based practices such as regular cardiovascular exercise, a balanced diet, and routine check-ups with your healthcare provider. Always discuss any health concerns or genetic test results with a qualified medical professional who can interpret them in the context of your full medical history.
How common is this variant?
The minor allele frequency for rs6857 is approximately 0.15-0.20 in European populations, making it a relatively common variant in that demographic.
Frequently asked questions
Is rs6857 a cause of Alzheimer's disease?
No, rs6857 is not considered a direct cause of Alzheimer's disease. It is located in a gene cluster that includes APOE, which is a known risk factor, but the association of rs6857 itself is limited and likely reflects its proximity to other influential genes.
Can I use rs6857 to predict my longevity?
Current scientific evidence does not support using rs6857 to predict individual longevity. While the gene cluster it resides in is studied for longevity, individual genetic variants have very small effects that are not useful for personal health forecasting.
Should I change my diet based on my APOC1 genotype?
There are no specific dietary recommendations based on the rs6857 variant. You should follow general heart-healthy dietary guidelines and consult with a registered dietitian or your doctor for personalized nutrition advice.
Where can I find more information about my genetic results?
You should discuss any genetic results with a certified genetic counselor or your primary care physician. They can help you understand the clinical relevance of your findings and how they relate to your overall health.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6857?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in APOC1
A chromosome 19 apolipoprotein gene cluster SNP associated with lipid metabolism and cognitive healthspan.
This variant is located in the APOE-APOC1-APOC4-APOC2 gene cluster and is strongly associated with plasma LDL cholesterol levels and cardiovascular disease risk.
A recurring polymorphism located in the non-coding region upstream of the APOC1 gene that contributes to cognitive impairment mechanisms.